Diagnostic accuracy of tests to detect hepatitis B surface antigen: a systematic review of the literature and meta-analysis
暂无分享,去创建一个
Debrah I. Boeras | Rosanna W. Peeling | Ali Amini | Roger Chou | Joseph D. Tucker | Weiming Tang | Jane Falconer | R. Peeling | R. Chou | P. Easterbrook | D. Boeras | J. Falconer | J. Tucker | A. Amini | Wen Chen | Philippa Easterbrook | A. Ishizaki | O. Varsaneux | Helen Kelly | Olivia Varsaneux | H. Kelly | Azumi Ishizaki | Wen Chen | W. Tang | Ali Amini
[1] S. Alavian,et al. HBsAg mutations related to occult hepatitis B virus infection in HIV‐positive patients result in a reduced secretion and conformational changes of HBsAg , 2017, Journal of medical virology.
[2] Vincent Wai-Sun Wong,et al. The role of quantitative hepatitis B surface antigen revisited. , 2017, Journal of hepatology.
[3] Reza Assadi,et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013 , 2016, The Lancet.
[4] Chien-Jen Chen,et al. Serum Levels of Hepatitis B Surface Antigen and DNA Can Predict Inactive Carriers With Low Risk of Disease Progression , 2016, Hepatology.
[5] F. Fall,et al. Short-term spontaneous fluctuations of HBV DNA levels in a Senegalese population with chronic hepatitis B , 2015, BMC Infectious Diseases.
[6] Maimuna Mendy,et al. Validation of Rapid Point-of-Care (POC) Tests for Detection of Hepatitis B Surface Antigen in Field and Laboratory Settings in the Gambia, Western Africa , 2015, Journal of Clinical Microbiology.
[7] Bernadette A. Thomas,et al. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.
[8] Michael Owusu,et al. Risk factors associated with hepatitis B exposure and the reliability of five rapid kits commonly used for screening blood donors in Ghana , 2014, BMC Research Notes.
[9] D. Glebe,et al. Overt and occult hepatitis B virus infection in adult Sudanese HIV patients. , 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[10] C. Wejse,et al. Hepatitis B virus surface antigen and anti‐hepatitis C virus rapid tests underestimate hepatitis prevalence among HIV‐infected patients , 2014, HIV medicine.
[11] M. Khuroo,et al. Accuracy of Rapid Point-of-Care Diagnostic Tests for Hepatitis B Surface Antigen-A Systematic Review and Meta-analysis. , 2014, Journal of clinical and experimental hepatology.
[12] O. Erhabor,et al. Comparison of ELISA and Rapid Screening Techniques for the Detection of HBsAg among Blood Donors in Usmanu Danfodiyo University Teaching Hospital Sokoto, North Western Nigeria , 2014 .
[13] K. Wannemuehler,et al. Prevalence of chronic hepatitis B virus infection before and after implementation of a hepatitis B vaccination program among children in Nepal. , 2014, Vaccine.
[14] I. Ekejindu,et al. Occult hepatitis B viral infection among blood donors in South–Eastern Nigeria , 2014, Pathogens and global health.
[15] M. Omrani,et al. Diagnostic validity of the chemiluminescent method compared to polymerase chain reaction for hepatitis B virus detection in the routine clinical diagnostic laboratory , 2014, Advanced biomedical research.
[16] R. Gish,et al. A simple and inexpensive point-of-care test for hepatitis B surface antigen detection: serological and molecular evaluation , 2014, Journal of viral hepatitis.
[17] Sheng Lin,et al. Evaluation of the performance of four methods for detection of hepatitis B surface antigen and their application for testing 116,455 specimens. , 2014, Journal of virological methods.
[18] Helen H. Lee,et al. Performance of a new rapid test for the detection of hepatitis B surface antigen in various patient populations. , 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[19] F. Noordeen,et al. Diagnostic efficacy of rapid assays used for the detection of hepatitis B virus surface antigen , 2013 .
[20] F. Carrat,et al. Performance of rapid tests for detection of HBsAg and anti-HBsAb in a large cohort, France. , 2013, Journal of hepatology.
[21] M. Tanner,et al. Viral Hepatitis and Rapid Diagnostic Test Based Screening for HBsAg in HIV-infected Patients in Rural Tanzania , 2013, PloS one.
[22] G. Gray,et al. Prevalence and associations with hepatitis B and hepatitis C infection among HIV-infected adults in South Africa , 2012, International journal of STD & AIDS.
[23] R. Peeling,et al. Rapid Point-of-Care First-Line Screening Tests for Hepatitis B Infection: A Meta-Analysis of Diagnostic Accuracy (1980–2010) , 2012, The American Journal of Gastroenterology.
[24] M. Manns,et al. Hepatitis B Surface Antigen Concentrations in Patients with HIV/HBV Co-Infection , 2012, PloS one.
[25] E. Skjerve,et al. Prevalence of hepatitis B & hepatitis C virus infections in potential blood donors in rural Vietnam , 2012, The Indian journal of medical research.
[26] D. Jamieson,et al. HIV-HBV coinfection--a global challenge. , 2012, The New England journal of medicine.
[27] C. Sureau,et al. Variable capacity of 13 hepatitis B virus surface antigen assays for the detection of HBsAg mutants in blood samples. , 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[28] Liming Cheng,et al. Development of an economic and efficient strategy to detect HBsAg: application of "gray-zones" in ELISA and combined use of several detection assays. , 2011, Clinica chimica acta; international journal of clinical chemistry.
[29] Susan Mallett,et al. Circulating MicroRNAs as a Novel Class of Diagnostic Biomarkers in Gastrointestinal Tumors Detection: A Meta-Analysis Based on 42 Articles , 2014, PloS one.
[30] S. Eholie,et al. Occult HBV infection in untreated HIV-infected adults in Côte d'Ivoire , 2010, Antiviral therapy.
[31] J. Li,et al. Hepatitis B virus transfusion risk in China: proficiency testing for the detection of hepatitis B surface antigen , 2010, Transfusion medicine.
[32] T. Gutteberg,et al. Screening test accuracy among potential blood donors of HBsAg, anti-HBc and anti-HCV to detect hepatitis B and C virus infection in rural Cambodia and Vietnam. , 2010, The Southeast Asian journal of tropical medicine and public health.
[33] William M. Lee,et al. Validity of the rapid strip assay test for detecting HBsAg in patients admitted to hospital in Uganda , 2010, Journal of medical virology.
[34] M. Brunetto,et al. Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers. , 2010, Gastroenterology.
[35] F. Sarfo,et al. Detection of Highly Prevalent Hepatitis B Virus Coinfection among HIV-Seropositive Persons in Ghana , 2010, Journal of Clinical Microbiology.
[36] H. Zeichhardt,et al. Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes , 2010, Vox sanguinis.
[37] Jian-ping Liu,et al. [Xiaochaihu Tang for treatment of chronic hepatitis B: a systematic review of randomized trials]. , 2010, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.
[38] N. Beeching,et al. Reliability of rapid testing for hepatitis B in a region of high HIV endemicity. , 2010, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[39] G. Odaibo,et al. Pitfalls in diagnosis of hepatitis B virus infection among adults Nigerians. , 2009, Nigerian journal of clinical practice.
[40] T. Gutteberg,et al. Prevalence of hepatitis B and hepatitis C virus infections in potential blood donors in rural Cambodia. , 2009, The Southeast Asian journal of tropical medicine and public health.
[41] P. Marcellin,et al. Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa‐2a in HBeAg‐negative chronic hepatitis B , 2009, Hepatology.
[42] R. Burnett,et al. Increased detection of HBV DNA in HBsAg‐positive and HBsAg‐negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital , 2009, Journal of medical virology.
[43] Helen H. Lee,et al. Evaluation of a New Hepatitis B Virus Surface Antigen Rapid Test with Improved Sensitivity , 2008, Journal of Clinical Microbiology.
[44] E. Ratsima,et al. Evaluation of the performance of four rapid tests for detection of hepatitis B surface antigen in Antananarivo, Madagascar. , 2008, Journal of virological methods.
[45] N. Beeching,et al. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi. , 2008, The Journal of infection.
[46] Sang-Hyun Hwang,et al. [Meta-analysis for the pooled sensitivity and specificity of hepatitis B surface antigen rapid tests]. , 2008, The Korean journal of laboratory medicine.
[47] P. Hewson,et al. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis. , 2007, Health technology assessment.
[48] M. Omrani,et al. Comparative Evaluation of Immunochromatographic Rapid Diagnostic Tests (Strip and Device) and PCR Methods for Detection of Human Hepatitis B Surface Antigens , 2007 .
[49] C. Muller,et al. Hepatitis B virus genotype E surface antigen detection with different immunoassays and diagnostic impact of mutations in the preS/S gene , 2007, Medical Microbiology and Immunology.
[50] K. Yamaguchi,et al. Evaluation of 10 commercial diagnostic kits for in vitro expressed hepatitis B virus (HBV) surface antigens encoded by HBV of genotypes A to H. , 2006, Journal of virological methods.
[51] A. Roque-Afonso,et al. Sensitivities of Four New Commercial Hepatitis B Virus Surface Antigen (HBsAg) Assays in Detection of HBsAg Mutant Forms , 2006, Journal of Clinical Microbiology.
[52] C. Okany,et al. Evaluation of a rapid test kit for detection of HBsAg/eAg in whole blood: a possible method for pre-donation testing. , 2006, African journal of medicine and medical sciences.
[53] F. Fabrizi,et al. Meta‐analysis: the effect of age on immunological response to hepatitis B vaccine in end‐stage renal disease , 2004, Alimentary pharmacology & therapeutics.
[54] D. Ganem,et al. Hepatitis B virus infection--natural history and clinical consequences. , 2004, The New England journal of medicine.
[55] Yoshinori Iwatani,et al. Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay. , 2004, Journal of virological methods.
[56] J. Hoofnagle,et al. A rapid immunochromatographic assay for hepatitis B virus screening , 2003, Journal of viral hepatitis.
[57] G. Leroux-Roels,et al. Evaluation of a New Rapid Test for the Combined Detection of Hepatitis B Virus Surface Antigen and Hepatitis B Virus e Antigen , 2002, Journal of Clinical Microbiology.
[58] P. Abraham,et al. Evaluation of an indigenously manufactured rapid immunochromatographic test for detection of HBsAg. , 2001, Indian journal of pathology & microbiology.
[59] A. Oberoi,et al. Evaluation of rapid kits for detection of HIV, HBsAg and HCV infections. , 2000, Indian journal of medical sciences.
[60] A. Corwin,et al. Evaluation of rapid diagnostic tests for the detection of human immunodeficiency virus types 1 and 2, hepatitis B surface antigen, and syphilis in Ho Chi Minh City, Vietnam. , 2000, The American journal of tropical medicine and hygiene.
[61] H. Yoon,et al. Evaluation of Genedia HBsAg Rapid and Genedia Anti-HBs Rapid for the Screening of HBsAg and Anti-HBs , 1999 .
[62] S. Ichiyama,et al. Evaluation of immunochromatographic assay systems for rapid detection of hepatitis B surface antigen and antibody, Dainascreen HBsAg and Dainascreen Ausab , 1996, Journal of clinical microbiology.
[63] P. Zacharias,et al. The use of rapid diagnostic tests for transfusion infectious screening in Africa: a literature review. , 2015, Transfusion medicine reviews.
[64] EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. , 2012, Journal of hepatology.
[65] D. Harnois,et al. Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B , 2011 .
[66] S. Zeuzem,et al. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. , 2011, Journal of hepatology.
[67] Huy Trinh,et al. Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B. , 2011, Gastroenterology.
[68] M. Usman,et al. Evaluation of the Performance of Two Rapid Immunochromatographic Tests for Detection of Hepatitis B Surface Antigen and Anti HCV Antibodies Using Elisa Tested Samples , 2010 .
[69] M. Busch,et al. Frequency of diagnostically significant hepatitis B surface antigen mutants , 2007 .
[70] R. Burnett,et al. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[71] H. Sommer,et al. Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays. , 2004, Clinical laboratory.
[72] G. Sridharan,et al. Evaluation of two immunochromatographic assays in relation to `RAPID' Screening of HBsAG , 1998 .
[73] N. Constantine,et al. Rapid and simple hepatitis assays: encouraging results from a blood donor population in Zimbabwe. , 1996, Bulletin of the World Health Organization.